Tuesday, December 07, 2004
Cheap drugs from Canada
The importation of drugs from Canada is bad public policy for a number of reasons which I and others have ranted about from time to time. I have always thought, though, that the "safety" argument advanced by the pharmaceutical industry and the FDA in opposition to drug reimportation was largely a crock. It is not, however, entirely a crock:
As is alleged in the complaint, FDA's investigation of Canada Care's illegal importation operations has revealed several products that pose a risk to the public health. In February and August 2004, FDA made two undercover purchases of the FDA-approved drugs Sporanox and Neurontin through Canada Care.
Instead of Neurontin, FDA received unapproved drugs called APO-Gabapentin and Novo-Gabapentin.
0 Comments:
